GOODYEAR TIRE & RUBBER CO (GT)       11.46  -0.19 (-1.63%)

11.46  -0.19 (-1.63%)

US3825501014 - Common Stock - After market: 11.4 -0.06 (-0.52%)


Fundamental Rating

4

Taking everything into account, GT scores 4 out of 10 in our fundamental rating. GT was compared to 46 industry peers in the Auto Components industry. While GT is still in line with the averages on profitability rating, there are some concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on GT.




Profitability

Profitability Rating

4

GT has a Return On Equity of 16.89%. This is better than the industry average of 11.03%.
GT's Profit Margin of 4.19% is in line with the rest of the industry. The industry average Profit Margin is 4.78%.

The Piotroski-F score of GT is 6.00. This is a neutral score and indicates average health and profitability for GT.
GT has a Return On Assets of 3.67%. This is below the industry average of 4.80%.
VS Industry

ROA (3.67%) VS Industry: 32% outperformed.

0.07
49.39

ROE (16.89%) VS Industry: 65% outperformed.

0.78
53.39

Profit Margin (4.19%) VS Industry: 42% outperformed.

0.07
3,419.23

Valuation

Valuation Rating

7

With a Price/Earnings Ratio of 6.37, the valuation of GT can be described as very cheap.
Compared to an average industry Price/Earning Ratio of 14.95, GT is valued rather cheaply. On top of this GT is cheaper than 93% of the companies listed in the same industry.
The Forward Price/Earnings Ratio of 6.18 indicates a rather cheap valuation of GT.

When comparing the current price to the book value of GT, it is valued rather cheaply. It is trading at 0.64 times its book value.
Compared to an average industry price book ratio of 1.83, GT is valued rather cheaply. On top of this, GT is cheaper than 95% of the companies listed in the same industry.
When comparing the Enterprise Value to EBITDA ratio of GT to the average industry ratio of 7.98, GT is valued rather cheaply.
VS Industry

Price/Earnings (6.37) VS Industry: 93% outperformed.

461.80
5.05

Price/Book (0.64) VS Industry: 95% outperformed.

64.68
0.47

Enterprise Value/ EBITDA (4.85) VS Industry: 77% outperformed.

64.02
2.75

Growth

Growth Rating

5

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Looking at the last year, GT shows a very strong growth in Revenue. The Revenue has grown by 27.39%.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
GT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.76%.

Based on estimates for the next 5 years, GT will show a small growth in Earnings Per Share. The EPS will grow by 8.75% on average per year.
The Revenue has been growing slightly by 2.89% on average over the past 5 years.
The Revenue is expected to grow by 4.57% on average over the next 5 years.
GT shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -12.60% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-12.6% -4.06% -5.76% -27.7% -4.66% 6.26% 8.75%
Revenue2.89% 4.14% 27.39% 19.43% 11.17% 8.41% 4.57%

Health

Health Rating

1

GT has a Current Ratio of 1.33. This is a normal value and indicates that GT is financially healthy and should not expect problems in meeting its short term obligations.
The Piotroski-F score of GT is 6.00. This is a neutral score and indicates average health and profitability for GT.
Compared to an average industry Current Ratio of 1.73, GT is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 0.68 indicates that GT may have some problems paying its short term obligations.

Compared to an average industry Quick Ratio of 1.03, GT is worse placed to pay its short term obligations than its industry peers. 94% of its industry peers have a better Quick Ratio.
Compared to an average industry Debt to Equity Ratio of 0.37, GT is requires more financing than its industry peers. 91% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 1.62, we must say that GT is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.66, GT is in worse financial health than its industry peers.
VS Industry

Debt/Equity (1.54) VS Industry: 9% outperformed.

14.23
0.00

Quick Ratio (0.68) VS Industry: 6% outperformed.

0.33
25.68

Current Ratio (1.33) VS Industry: 25% outperformed.

0.71
25.68

Altman-Z (1.62) VS Industry: 28% outperformed.

-6.64
21.59

Dividend

Dividend Rating

0

No dividends for GT!.

GOODYEAR TIRE & RUBBER CO11.46

NASDAQ:GT (2/3/2023, 7:00:01 PM)-0.19 (-1.63%)

After market: 11.4 -0.06 (-0.52%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Automobiles & Components
GICS Industry Auto Components
Earnings (Last) 10-31 2022-10-31/amc Earnings (Next) 02-09 2023-02-09/amc
Inst Owners 80.64% Inst Owner Change -0.44%
Ins Owners 0.38% Ins Owner Change 0%
Market Cap 3.24B Analysts 78.82
Price Target 14.43 (25.92%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP 0%
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -2.44%
Min EPS beat(2) -27.91% Max EPS beat(2) 23.03%
EPS beat(4) 3 Avg EPS beat(4) 34.26%
Min EPS beat(4) -27.91% Max EPS beat(4) 71.64%
Revenue beat(2) 1 Avg Revenue beat(2) -0.6%
Min Revenue beat(2) -2.78% Max Revenue beat(2) 1.58%
Revenue beat(4) 2 Avg Revenue beat(4) 0.06%
Min Revenue beat(4) -2.78% Max Revenue beat(4) 2.57%
PT rev (1m) 0% PT rev (3m) -11.42%
EPS NQ rev (1m) -10.97% EPS NQ rev (3m) -64.28%
EPS NY rev (1m) 0% EPS NY rev (3m) -28.24%
Revenue NQ rev (1m) -1.97% Revenue NQ rev (3m) -3.64%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.99%

Valuation
Industry RankSector Rank
PE 6.37
Fwd PE 6.18
P/S 0.16
P/FCF N/A
P/OCF 7.42
P/B 0.64
P/tB 1.05
EV/EBITDA 4.85
EPS(TTM) 1.8 EY 15.71%
EPS(NY) 1.85 Fwd EY 16.18%
FCF(TTM) -2.27 FCFY N/A
OCF(TTM) 1.54 OCFY 13.48%
SpS 72.42 BVpS 17.98
TBVpS 10.89 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 3.67%
ROE 16.89%
ROIC 5.4%
ROICexc 5.85%
ROICexgc 6.73%
OM 5.5%
PM 4.19%
GM 19.88%
ROICexgc(3y) N/A ROICexcg growth 3Y -13.6%
ROICexcg growth 5Y -14.43% ROICexc(3y) N/A
ROICexc growth 3Y -16.27% ROICexc growth 5Y -16%
OM growth 3Y -14.43% OM growth 5Y -13.88%
PM growth 3Y -0.8% PM growth 5Y -12.12%
GM growth 3Y -1.56% GM growth 5Y -4.74%
F-Score 6 Asset Turnover 0.88

Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 4.15
Cap/Depr 112.97%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.68
Altman-Z 1.62
F-Score 6 WACC 8.07%
ROIC/WACC 0.83 Cap/Depr(3y) 164.49%
Cap/Depr(5y) 142.1% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -5.76% EPS 3Y -4.06%
EPS 5Y -12.6% EPS growth Q2Q -44.44%
EPS Next Y -27.7% EPS Next 2Y -4.66%
EPS Next 3Y 6.26% EPS Next 5Y 8.75%
Revenue growth 1Y 27.39% Revenue growth 3Y 4.14%
Revenue growth 5Y 2.89% Revenue growth Q2Q 7.64%
Revenue Next Year 19.43% Revenue Next 2Y 11.17%
Revenue Next 3Y 8.41% Revenue Next 5Y 4.57%
EBIT growth 1Y 39.01% EBIT growth 3Y -10.88%
EBIT growth 5Y -11.4% EBIT Next Year 79.72%
EBIT Next 3Y 27.95% EBIT Next 5Y 22.19%
FCF growth 1Y -256.45% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -60.52%
OCF growth 3Y 5.05% OCF growth 5Y -6.72%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA